You've Tried Everything Money Can Buy. Here's What You Haven't Tried.
You've done the full version — the psychiatrist with the waitlist, the therapist who trained under someone famous, the genetic test, the wellness retreat, the ketamine clinic. Some of it helped, a little, for a while. None of it fixed it. Here's what has actually changed in depression treatment, and why the best-resourced patients often end up in the most outdated care.
Last updated November 3, 2026.
Want to know if SAINT® is right for you?
Tell us about your treatment history and symptoms. A consultation is an evaluation, not a commitment — and it starts with your story.
You've done the work. Not the halfway version. The full version.
The psychiatrist with the six-month waitlist and the office in the right building. The therapist who trained under someone famous. The second opinion, and the third. The genetic test that was supposed to tell you which medication would finally work. The wellness retreat. The ketamine clinic. The executive coach who turned out to be a therapist in a nicer suit. The supplements, the sleep lab, the functional medicine doctor, the trip somewhere quiet.
Some of it helped, a little, for a while. None of it fixed it. And you have arrived at a strange place: you have every resource a person could reasonably want, and you are still depressed.
This article isn't going to tell you to try harder. You've tried. It's going to tell you what has actually changed in depression treatment, why the best-resourced patients often end up in the most outdated care, and where the real frontier is right now.
Why resources haven't been enough
It isn't because you picked the wrong doctor. It's because the entire standard toolkit, from the cheapest generic SSRI to the most expensive private psychiatrist, is working on the same mechanism. Chemistry.
Antidepressants adjust the chemical environment between neurons. For a majority of people, that's enough. But for roughly a third of people with major depression, it isn't, no matter how many variations they try or how carefully the trials are managed. Once you've had two adequate trials without remission, the odds of the next one working drop to around 14 percent. That number doesn't improve with a better psychiatrist. It's a property of the illness, not the care.
The reason is that depression isn't only a chemistry problem. It's a circuitry problem. The region behind the forehead called the dorsolateral prefrontal cortex, which regulates mood, motivation, and attention, is underactive in depression, and its connections to the rest of the mood network are weakened. No pill retrains that circuit directly. That's the ceiling you've been hitting.
The problem with "the best care"
Here's something uncomfortable about high-end psychiatric care: it is often excellent at a slow, careful version of the same approach that failed. More time per visit. More thoughtful medication management. Better bedside manner. But the same tools.
Meanwhile, the actual advances in depression treatment over the last decade have come from academic neuroscience labs, not from private practice. And the most significant of them, an FDA-cleared brain stimulation protocol that produces remission in days rather than months, is still unknown to most of the psychiatrists people pay the most to see.
If you've been assuming that the most expensive care must be the most advanced care, that assumption is what's been costing you.
Curious whether you'd qualify?
If you've tried medication and you're still not yourself, you may be a candidate for SAINT®. Our team will give you a straight answer.
What the frontier actually looks like
SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) was developed at Stanford's Brain Stimulation Lab by psychiatrists and neuroscientists working on precisely the problem you have: depression that has failed medication. It received FDA Breakthrough Device Designation and was cleared in 2022 for adults with major depressive disorder who haven't gotten adequate relief from antidepressants in their current episode.
It is not a better pill. It's a different mechanism, and it's built on three things the standard toolkit doesn't have.
- Your brain, imaged. Before treatment, you undergo a functional MRI, roughly 45 minutes, that maps how your individual brain networks are wired and where they're communicating poorly. This is the only FDA-cleared depression treatment that uses your own brain imaging to plan your care.
- Precision targeting. A targeting algorithm analyzes that scan and identifies the exact location where stimulation will most effectively reach the depression network. Neuronavigation guides the treatment coil to that spot, for every session, within millimeters. Standard TMS locates its target using external measurements of the head. This is the difference between a map and a GPS.
- A dose that actually moves the circuit. SAINT delivers ten 10-minute sessions per day, spaced with 50-minute breaks, over five consecutive days. The total stimulation exceeds an entire six-to-nine-week course of conventional TMS, compressed into a week. No anesthesia. Nothing enters your bloodstream. You're awake, and you go home each evening.
The data
In the published clinical trials behind SAINT's clearance, participants had treatment-resistant depression and had already failed prior treatments. Seventy-nine percent reached remission, not merely improvement, with an average time to remission of 2.6 days. Across more than 400 patients treated in trials, 85 percent experienced symptom relief, with no serious adverse events.
For comparison, remission rates in similar treatment-resistant populations: another medication trial, about 14 percent; esketamine, 16 to 37 percent over months of maintenance dosing; standard TMS, 17 to 32 percent after six to nine weeks; ECT, 48 percent, with anesthesia and memory risk.
The most common side effects were mild headache, fatigue, and temporary scalp discomfort. SAINT isn't appropriate for people with non-removable metal in or near the head or an implanted device. You don't have to stop your current medications.
Data from published trials in treatment-resistant depression. Individual results vary.
What it costs, and why that's not the point
Insurance coverage for SAINT is expanding but uneven. Some plans cover it with prior authorization; others don't yet. Self-pay is available.
If money hasn't been your obstacle, you already know what actually is: time, and the accumulated weight of treatments that didn't work. Every failed trial has cost you months. SAINT is five days, and most patients notice a shift in mood within the first two or three.
What you're buying isn't luxury. It's the most advanced, evidence-backed protocol that exists for the specific problem you have, delivered with the precision it was designed for.
What to do next
At Neuro Wellness TMS Centers of America, a Verified SAINT Provider, the first appointment is an evaluation, not a commitment. We offer private outpatient care with a dedicated care team and weekend availability. We'll review your full treatment history, which we expect to be extensive, and tell you honestly whether SAINT is the right next step. If it is, we'll schedule the scan and the treatment week around your calendar. If it isn't, we'll tell you what is.
Schedule a consultation: 954-827-9793
If you are in crisis or thinking about harming yourself, call or text 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room. This article is for educational purposes and is not a substitute for individual medical advice.
Frequently Asked Questions
Why hasn't the best psychiatric care I could buy fixed my depression?
What makes SAINT different from what I've already tried?
What are the remission rates for SAINT versus other options?
How long does SAINT take, and do I have to stop my medications?
Is SAINT FDA-cleared?
Explore Related Resources
How to Do Due Diligence on a Depression Treatment
An eight-question framework for evaluating any depression treatment — FDA status, remission rates, mechanism, and time cost.
The Executive Who Can't Afford Six Weeks
Why high performers get stuck in partial treatment, and why the schedule — not the cost — is the real barrier.
High-Functioning Depression: When Holding It Together Is the Problem
When functioning hides the severity of depression — and why partial relief isn't the goal.
How SAINT® Compares to Other Depression Treatment Options
A side-by-side comparison of SAINT® against medication, standard TMS, esketamine, and ECT.
Ready to talk to someone?
The hardest part is usually the first phone call. Everything after that is a series of small, defined steps.
You Don't Have to Figure This Out Alone
Schedule a Consultation